Format
Items per page
Sort by

Send to:

Choose Destination

Results: 19

1.

Lack of Associations between Body Mass Index and Clinical Outcomes in Patients with Papillary Thyroid Carcinoma.

Kwon H, Kim M, Choi YM, Jang EK, Jeon MJ, Kim WG, Kim TY, Shong YK, Song DE, Baek JH, Hong SJ, Kim WB.

Endocrinol Metab (Seoul). 2014 Nov 26. [Epub ahead of print]

2.

The influence of body mass index on the diagnostic performance of pre-operative staging ultrasound in papillary thyroid carcinoma.

Choi JS, Lee HS, Kim EK, Moon HJ, Kwak JY.

Clin Endocrinol (Oxf). 2014 Oct 17. doi: 10.1111/cen.12638. [Epub ahead of print]

PMID:
25323560
3.

The incidence of papillary thyroid carcinoma and outcomes in operative patients according to their body mass indices.

Trésallet C, Seman M, Tissier F, Buffet C, Lupinacci RM, Vuarnesson H, Leenhardt L, Menegaux F.

Surgery. 2014 Nov;156(5):1145-52. doi: 10.1016/j.surg.2014.04.020. Epub 2014 May 27.

PMID:
24878452
4.

Obesity and the risk of papillary thyroid cancer: a pooled analysis of three case-control studies.

Xu L, Port M, Landi S, Gemignani F, Cipollini M, Elisei R, Goudeva L, Müller JA, Nerlich K, Pellegrini G, Reiners C, Romei C, Schwab R, Abend M, Sturgis EM.

Thyroid. 2014 Jun;24(6):966-74. doi: 10.1089/thy.2013.0566. Epub 2014 May 5.

PMID:
24555500
5.
6.

Incretin-based therapies in the treatment of type 2 diabetes--more than meets the eye?

Labuzek K, Kozłowski M, Szkudłapski D, Sikorska P, Kozłowska M, Okopień B.

Eur J Intern Med. 2013 Apr;24(3):207-12. doi: 10.1016/j.ejim.2013.01.009. Epub 2013 Jan 31. Review.

PMID:
23375875
7.

Neck circumference correlates with tumor size and lateral lymph node metastasis in men with small papillary thyroid carcinoma.

Kim MR, Kim SS, Huh JE, Lee BJ, Lee JC, Jeon YK, Kim BH, Kim SJ, Wang SG, Kim YK, Kim IJ.

Korean J Intern Med. 2013 Jan;28(1):62-71. doi: 10.3904/kjim.2013.28.1.62. Epub 2012 Dec 28.

8.

Overweight, obesity and thyroid cancer risk: a meta-analysis of cohort studies.

Zhao ZG, Guo XG, Ba CX, Wang W, Yang YY, Wang J, Cao HY.

J Int Med Res. 2012;40(6):2041-50.

PMID:
23321160
9.

Recreational physical activity and risk of papillary thyroid cancer among women in the California Teachers Study.

Cash SW, Ma H, Horn-Ross PL, Reynolds P, Canchola AJ, Sullivan-Halley J, Beresford SA, Neuhouser ML, Vaughan TL, Heagerty PJ, Bernstein L.

Cancer Epidemiol. 2013 Feb;37(1):46-53. doi: 10.1016/j.canep.2012.09.003. Epub 2012 Oct 30.

10.

Common obesity-related genetic variants and papillary thyroid cancer risk.

Kitahara CM, Neta G, Pfeiffer RM, Kwon D, Xu L, Freedman ND, Hutchinson AA, Chanock SJ, Sturgis EM, Sigurdson AJ, Brenner AV.

Cancer Epidemiol Biomarkers Prev. 2012 Dec;21(12):2268-71. doi: 10.1158/1055-9965.EPI-12-0790. Epub 2012 Oct 11.

11.

Expression and biologic significance of adiponectin receptors in papillary thyroid carcinoma.

Cheng SP, Liu CL, Hsu YC, Chang YC, Huang SY, Lee JJ.

Cell Biochem Biophys. 2013 Mar;65(2):203-10. doi: 10.1007/s12013-012-9419-1.

PMID:
22907586
12.

Associations between body mass index and clinico-pathological characteristics of papillary thyroid cancer.

Kim HJ, Kim NK, Choi JH, Sohn SY, Kim SW, Jin SM, Jang HW, Suh S, Min YK, Chung JH, Kim SW.

Clin Endocrinol (Oxf). 2013 Jan;78(1):134-40. doi: 10.1111/j.1365-2265.2012.04506.x.

PMID:
22812676
13.

Regulation of leptin receptor expression in human papillary thyroid cancer cells.

Cheng SP, Liu CL, Hsu YC, Chang YC, Huang SY, Lee JJ.

Biomed Pharmacother. 2012 Sep;66(6):469-73. doi: 10.1016/j.biopha.2012.03.008. Epub 2012 Mar 31.

PMID:
22560341
14.

Leptin: a correlated Peptide to papillary thyroid carcinoma?

Hedayati M, Yaghmaei P, Pooyamanesh Z, Zarif Yeganeh M, Hoghooghi Rad L.

J Thyroid Res. 2011;2011:832163. doi: 10.4061/2011/832163. Epub 2011 Oct 5.

15.

Diabetes and thyroid cancer risk in the National Institutes of Health-AARP Diet and Health Study.

Aschebrook-Kilfoy B, Sabra MM, Brenner A, Moore SC, Ron E, Schatzkin A, Hollenbeck A, Ward MH.

Thyroid. 2011 Sep;21(9):957-63. doi: 10.1089/thy.2010.0396. Epub 2011 Jul 18.

16.

Leptin enhances migration of human papillary thyroid cancer cells through the PI3K/AKT and MEK/ERK signaling pathways.

Cheng SP, Yin PH, Hsu YC, Chang YC, Huang SY, Lee JJ, Chi CW.

Oncol Rep. 2011 Nov;26(5):1265-71. doi: 10.3892/or.2011.1388. Epub 2011 Jul 12.

PMID:
21750869
17.

Fatal heart failure after a 26-month combination of tyrosine kinase inhibitors in a papillary thyroid cancer.

Toubert ME, Vercellino L, Faugeron I, Lussato D, Hindie E, Bousquet G.

Thyroid. 2011 Apr;21(4):451-4. doi: 10.1089/thy.2010.0270. Epub 2011 Mar 8.

PMID:
21385075
18.

Clinicopathologic significance of leptin and leptin receptor expressions in papillary thyroid carcinoma.

Cheng SP, Chi CW, Tzen CY, Yang TL, Lee JJ, Liu TP, Liu CL.

Surgery. 2010 Jun;147(6):847-53. doi: 10.1016/j.surg.2009.11.004. Epub 2009 Dec 31.

PMID:
20045163
19.

Endocrine dysfunction and parameters of the metabolic syndrome after bone marrow transplantation during childhood and adolescence.

Shalitin S, Phillip M, Stein J, Goshen Y, Carmi D, Yaniv I.

Bone Marrow Transplant. 2006 Jun;37(12):1109-17. Epub 2006 May 8.

PMID:
16699534
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk